# Gerald Chan

> Gerald Chan is a Series C investor at Morningside backing Biotechnology and Pharmaceutical. See 1 investments, check sizes, portfolio. Updated Aug 2026.

- Type: Angel Investor
- Fund: [Morningside](https://shizune.co/investors/profile/morningside-technology-ventures)
- Total investments: 1
- Last investment: Sep 2020
- Lead investor: 0%
- Last updated: Aug 2026

Gerald Chan is a Series C investor at Morningside focused on Biotechnology and Pharmaceutical. Qin Liu is the founder of Morningside Venture Investments.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Biotechnology | 1 | 100% |
| Pharmaceutical | 1 | 100% |
| Artificial Intelligence | 1 | 100% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| XtalPi | XtalPi is a pharmaceutical technology company that is reinventing the industry’s approach to drug research and development with its Intelligent Digital Drug Discovery and Development (ID4) platform. Through its tightly interwoven quantum mechanics, artificial intelligence, and high-performance cloud computing algorithms, the ID4 platform enablespharmaceutical companies to increase their efficiency, accuracy, and success rate at critical stages of drug R&D. By accelerating the pace of drug discovery and development, XtalPi aims to contribute to a healthier society worldwide.Founded in 2014 by a group of quantum physicists at MIT, XtalPi has since grown into an elite team of researchers with multi-disciplinary expertise in physics, chemistry, pharmaceutical R&D, and algorithm design. XtalPi has received much recognition for its cutting-edge technologies, its innovative solutions, and the breadth of potential applications of its offerings across the pharmaceutical value chain, which has allowed it to gain industry approval and establish strategic partnerships with several top international pharmaceutical companies. | $318.8M | Series C | Sep 28, 2020 |  |

1 of 1 investments shown.

## Co-investors
- [CITIC Capital Holdings](https://shizune.co/investors/profile/citic-capital-holdings) — VC Fund, 1 deal together
- [CMB International's Telecom Fund.](https://shizune.co/investors/profile/cmb-international-s-telecom-fund) — VC Fund, 1 deal together
- [HSG](https://shizune.co/investors/profile/hsg-cap) — VC Fund, 1 deal together
- [IMO Ventures](https://shizune.co/investors/profile/immersion-ventures) — VC Fund, 1 deal together
- [Mirae Asset](https://shizune.co/investors/profile/mirae-asset-global-investments) — VC Fund, 1 deal together
- [5Y Capital](https://shizune.co/investors/profile/morningsidevc) — VC Fund, 1 deal together

## About Morningside

VC Fund · Shanghai, China

Morningside makes venture capital investments in companies with novel science and technology. We are characterized by a long-term outlook in company-building and an unwavering commitment to acting ethically.Based in the greater Boston area, our team of entrepreneurial investment professionals has deep experience in life sciences, digital health,AI, materials and technology.Founded in 1986 as a family office for the Chan family, charitable commitments to education, research and healthcare include the Harvard T.H. Chan School of Public Health, the UMass Chan Medical School, and the MIT Morningside Academy for Design.

5 contacts available at Morningside.

| Name | Title | Profile |
| --- | --- | --- |
| Anthony Aiudi | Investment Professional | https://shizune.co/investors/profile/anthony-aiudi |
| Mick Sawka | Investment Manager | https://shizune.co/investors/profile/mick-sawka |
| Gerald Chan | Co-Founder, Investment Director & Board Member | https://shizune.co/investors/profile/qin-liu-f6a9 |
| Justin Burns | Investment Professional | https://shizune.co/investors/profile/justin-burns-de33 |
| Michael Xue | Managing Director | https://shizune.co/investors/profile/michael-xue-bf20 |

## Similar investors

### Similar stage
- [Sequoia Capital](https://shizune.co/investors/profile/sequoia-capital) — VC Fund
- [New Enterprise Associates](https://shizune.co/investors/profile/new-enterprise-associates) — VC Fund
- [Bessemer Venture Partners](https://shizune.co/investors/profile/bessemer-venture-partners) — VC Fund

## FAQ

### What does Gerald Chan invest in?

Gerald Chan invests primarily in Biotechnology, Pharmaceutical and Artificial Intelligence startups, most often at Series C stage. Most of the 1 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Gerald Chan last invest?

The most recent investment recorded for Gerald Chan closed in Sep 2020. Shizune tracks 1 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co